Genetic Signatures Ltd
ASX:GSS

Watchlist Manager
Genetic Signatures Ltd Logo
Genetic Signatures Ltd
ASX:GSS
Watchlist
Price: 0.63 AUD -3.82%
Market Cap: 143.1m AUD
Have any thoughts about
Genetic Signatures Ltd?
Write Note

Wall Street
Price Targets

GSS Price Targets Summary
Genetic Signatures Ltd

Wall Street analysts forecast GSS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSS is 1.12 AUD with a low forecast of 1.11 AUD and a high forecast of 1.16 AUD.

Lowest
Price Target
1.11 AUD
76% Upside
Average
Price Target
1.12 AUD
78% Upside
Highest
Price Target
1.16 AUD
83% Upside
Genetic Signatures Ltd Competitors:
Price Targets
PPGN
PolyPeptide Group AG
14% Upside
CSBR
Champions Oncology Inc
4% Upside
RVU
Ryvu Therapeutics SA
110% Upside
MLC
Malin Corporation PLC
83% Upside
CDXS
Codexis Inc
40% Upside
MEDP
Medpace Holdings Inc
5% Upside
DXRX
Diaceutics PLC
43% Upside
688114
MGI Tech Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Genetic Signatures Ltd

For the last 8 years the compound annual growth rate for Genetic Signatures Ltd's revenue is 20%. The projected CAGR for the next 3 years is 73%.

20%
Past Growth
73%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Genetic Signatures Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Genetic Signatures Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSS's stock price target?
Price Target
1.12 AUD

According to Wall Street analysts, the average 1-year price target for GSS is 1.12 AUD with a low forecast of 1.11 AUD and a high forecast of 1.16 AUD.

What is Genetic Signatures Ltd's Revenue forecast?
Projected CAGR
73%

For the last 8 years the compound annual growth rate for Genetic Signatures Ltd's revenue is 20%. The projected CAGR for the next 3 years is 73%.

Back to Top